A transgenic non-human animal with a homologous disruption of the KSR-2 gene is disclosed. Methods for using transgenic mice so generated to screen for agents that effect cellular metabolism are also provided.
Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"